文献
J-GLOBAL ID:201802286458111162
整理番号:18A0468665
OAB患者における単剤療法とプラセボと比較したミラベグロンとソリフェナシンの組合せを評価する相乗作用,無作為化,二重盲検,多施設研究からの患者報告転帰【Powered by NICT】
Patient-reported outcomes from SYNERGY, a randomized, double-blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patients
著者 (12件):
Robinson Dudley
(King’s College Hospital, London, UK)
,
Kelleher Con
(Guy’s and St Thomas’ Hospital, London, UK)
,
Staskin David
(Tufts University School of Medicine, Boston, Massachusetts)
,
Mueller Elizabeth R.
(Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois)
,
Falconer Christian
(Karolinska Institute, Stockholm, Sweden)
,
Wang Jianye
(Beijing Hospital, Beijing, China)
,
Ridder Arwin
(Astellas Pharma Global Development, Leiden, Netherlands)
,
Stoelzel Matthias
(Astellas Pharma Global Development, Leiden, Netherlands)
,
Paireddy Asha
(Astellas Pharma Global Development, Leiden, Netherlands)
,
van Maanen Rob
(Astellas Pharma Global Development, Leiden, Netherlands)
,
Hakimi Zalmai
(Astellas Pharma Europe Ltd, Surrey, UK)
,
Herschorn Sender
(Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada)
資料名:
Neurourology and Urodynamics
(Neurourology and Urodynamics)
巻:
37
号:
1
ページ:
394-406
発行年:
2018年
JST資料番号:
W2696A
ISSN:
0733-2467
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)